Skip to main content
Fig. 2 | Respiratory Research

Fig. 2

From: Risk of all-cause mortality or hospitalization for pneumonia associated with inhaled β2-agonists in patients with asthma, COPD or asthma-COPD overlap

Fig. 2

Flowchart of number of patients in the base and study cohort. CPRD: Clinical Practice Research Datalink; OADs: obstructive airway diseases; COPD: chronic obstructive pulmonary disease; ACO: asthma-COPD overlap; ICS: inhaled corticosteroid; LABA: long-acting beta-agonist; LAMA: long-acting muscarinic antagonist; SABA: short-acting beta-agonist; SAMA: short-acting muscarinic antagonist; Rx: prescription

Back to article page

Respiratory Research

ISSN: 1465-993X

Contact us